Post-acute Sequelae of Sars-cov-2 Infection
📧 Sign up to get email alerts when something new happens for Post-acute Sequelae of Sars-cov-2 Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Nutrition and LOComotoric Rehabilitation in Long COVID-19 [NA]
This clinical trial update reports the completion of a study evaluating nutrition and locomotor rehabilitation for individuals with COVID-19…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) for Post COVID-19 Fatigue [NA]
A completed clinical trial from the University of Iowa evaluated transcranial direct current stimulation (tDCS) for fatigue in patients with…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID-19 Cognitive Dysfunction [Phase 1]
This Phase 1 open-label pilot study evaluating Hi-OXSR for treating post-COVID-19 cognitive dysfunction has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection [Phase 2]
Phase 2 trial update on AXA1125 for fatigue after COVID-19 infection reports efficacy, safety, and tolerability results.
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. [Phase 2]
Phase 2 clinical trial evaluating safety, tolerability and efficacy of S-1226 in adults with persistent respiratory symptoms after COVID-19 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.